StonvexLoading…
StonvexStonvexStonvexCore line items from PTCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.73B | $806.78M | $937.82M | $698.80M |
Operating Income | $866.93M | $-302.57M | $-439.50M | $-447.41M |
Net Income | $682.64M | $-363.30M | $-626.60M | $-559.02M |
EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 |
Total Assets | $2.90B | $1.71B | $1.90B | $1.71B |
Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B |
Cash & Equivalents | $984.65M | $779.71M | $594.00M | $279.83M |
Free Cash Flow OCF − CapEx | $702.34M | $-114.19M | $-186.86M | $-388.67M |
Shares Outstanding | 81.47M | 77.70M | 75.71M | 73.10M |